Literature DB >> 21543555

Microsomal quercetin glucuronidation in rat small intestine depends on age and segment.

Bradley W Bolling1, Michael H Court, Jeffrey B Blumberg, C-Y Oliver Chen.   

Abstract

UDP-glucuronosyltransferase (UGT) activity toward the flavonoid quercetin and UGT protein were characterized in three equidistant small intestine (SI) segments from 4-, 12-, 18-, and 28-month-old male Fischer 344 rats (n = 8/age) using villin to control for enterocyte content. SI microsomal intrinsic clearance of quercetin was increased 3- to 9-fold from 4 months in the proximal and distal SI at 12 and 18 months. Likewise, at 30 μM quercetin, SI microsomal glucuronidation activity was increased with age: 4.8- and 3.9-fold greater at 18 months than at 4 months. Quercetin UGT regioselectivity was not changed by age. The distal SI preferentially catalyzed glucuronidation at the 7-position, whereas the proximal SI produced the greatest proportion of 4'- and 3'-conjugates. Enterocyte UGT content in different SI segments was not consistently changed with age. In the proximal SI, UGT1A increased 64 and 150% at 12 and 18 months and UGT1A1, UGT1A7, and UGT1A8 were also increased at 12 and 18 months. However, age-related changes in expression were inconsistent in the medial and distal segments. Microsomal rates of quercetin glucuronidation and UGT expression were positively correlated with UGT1A1 content for all pooled samples (r = 0.467) and at each age (r = 0.538-0.598). UGT1A7 was positively correlated with total, 7-O- and 3-O-quercetin glucuronidation at 18 months. Thus, age-related differences in UGT quercetin glucuronidation depend on intestinal segment, are more pronounced in the proximal and distal segments and may be partially related to UGT1A1 and UGT1A7 content.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543555      PMCID: PMC3141883          DOI: 10.1124/dmd.111.038406

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  46 in total

1.  Bioavailability of [2-(14)C]quercetin-4'-glucoside in rats.

Authors:  William Mullen; Jean-Max Rouanet; Cyril Auger; Pierre-Louis Teissèdre; Stuart T Caldwell; Richard C Hartley; Micheal E J Lean; Christine A Edwards; Alan Crozier
Journal:  J Agric Food Chem       Date:  2008-12-24       Impact factor: 5.279

2.  Up-regulation of glutathione S-transferase activity in enterocytes of young children.

Authors:  J P Gibbs; C A Liacouras; R N Baldassano; J T Slattery
Journal:  Drug Metab Dispos       Date:  1999-12       Impact factor: 3.922

3.  Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin.

Authors:  A J Day; F Mellon; D Barron; G Sarrazin; M R Morgan; G Williamson
Journal:  Free Radic Res       Date:  2001-12

4.  Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.

Authors:  Marelle G Boersma; Hester van der Woude; Jan Bogaards; Sjef Boeren; Jacques Vervoort; Nicole H P Cnubben; Marlou L P S van Iersel; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Chem Res Toxicol       Date:  2002-05       Impact factor: 3.739

5.  Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions.

Authors:  William Mullen; Christine A Edwards; Alan Crozier
Journal:  Br J Nutr       Date:  2006-07       Impact factor: 3.718

6.  Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9.

Authors:  Yakun Chen; Shenggu Xie; Shuqing Chen; Su Zeng
Journal:  Biochem Pharmacol       Date:  2008-05-15       Impact factor: 5.858

7.  Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.

Authors:  Walter Brand; Marelle G Boersma; Hanneke Bik; Elisabeth F Hoek-van den Hil; Jacques Vervoort; Denis Barron; Walter Meinl; Hansruedi Glatt; Gary Williamson; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Drug Metab Dispos       Date:  2010-01-07       Impact factor: 3.922

Review 8.  Quercetin: potentials in the prevention and therapy of disease.

Authors:  Stephan C Bischoff
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-11       Impact factor: 4.294

9.  Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.

Authors:  K S Lown; J C Kolars; K E Thummel; J L Barnett; K L Kunze; S A Wrighton; P B Watkins
Journal:  Drug Metab Dispos       Date:  1994 Nov-Dec       Impact factor: 3.922

10.  Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10.

Authors:  Upendra A Argikar; Rory P Remmel
Journal:  Drug Metab Dispos       Date:  2008-10-06       Impact factor: 3.922

View more
  4 in total

1.  Hepatoenteric recycling is a new disposition mechanism for orally administered phenolic drugs and phytochemicals in rats.

Authors:  Yifan Tu; Lu Wang; Yi Rong; Vincent Tam; Taijun Yin; Song Gao; Rashim Singh; Ming Hu
Journal:  Elife       Date:  2021-07-01       Impact factor: 8.140

2.  Plasma quercetin metabolites are affected by intestinal microbiota of human microbiota-associated mice fed with a quercetin-containing diet.

Authors:  Motoi Tamura; Hiroyuki Nakagawa; Sachiko Hori; Tadahiro Suzuki; Kazuhiro Hirayama
Journal:  J Clin Biochem Nutr       Date:  2019-10-10       Impact factor: 3.114

3.  Inhibitory effects of quercetin and its major metabolite quercetin-3-O-β-D-glucoside on human UDP-glucuronosyltransferase 1A isoforms by liquid chromatography-tandem mass spectrometry.

Authors:  Rui Zhang; Ye Wei; Tingyu Yang; Xixi Huang; Jinping Zhou; Chunxiao Yang; Jiani Zhou; Yani Liu; Shaojun Shi
Journal:  Exp Ther Med       Date:  2021-06-06       Impact factor: 2.447

4.  Glucuronidation as a metabolic barrier against zearalenone in rat everted intestine.

Authors:  Takahiro Ieko; Sumire Inoue; Yume Inomata; Hiroki Inoue; Jumpei Fujiki; Hidetomo Iwano
Journal:  J Vet Med Sci       Date:  2019-12-16       Impact factor: 1.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.